JI-YOUN HAN
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Brigatinib in ALK-positive NSCLC Identified Via Blood-based Assays (NCT04074993) | JI-YOUN HAN | 2020-05-15 |
Track JI-YOUN HAN automatically
Every clearance here is in the API, with alerts when new ones post.